Medication History versus Point-of-Care Platelet Activity Testing in Patients with Intracerebral Hemorrhage

0

We evaluated whether reduced platelet activity detected by point-of-care (POC) testing is a better predictor of hematoma expansion and poor functional outcomes in patients with intracerebral hemorrhage (ICH) than a history of antiplatelet medication exposure.

Read More...

Leave A Reply